Viveon Health Acquisition announced the underwriters of its IPO exercised their over-allotment option resulting in the issuance of an additional 2.625 million units, generating $26.25 million.
The units trade on the NYSE American under VHAQU.
Once the securities begin separate trading, the shares of common stock, redeemable warrants, and rights are expected to be listed on the NYSE American under VHAQ, VHAQW, and VHAQR, respectively.
Viveon is focused on healthcare companies in North America, especially orthopedics.
The over-allotment option was granted in connection with the public offering of 17.5 million units at $10 each, which closed earlier this week. Read more.
